A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Days to Less Than 12 Weeks Old With Autosomal Recessive Polycystic Kidney Disease (ARPKD)
- Conditions
- Autosomal Recessive Polycystic Kidney Disease (ARPKD)
- Interventions
- First Posted Date
- 2021-03-08
- Last Posted Date
- 2023-09-15
- Target Recruit Count
- 20
- Registration Number
- NCT04786574
- Locations
- 🇺🇸
Johns Hopkins Pediatric Specialty Clinic, Baltimore, Maryland, United States
🇺🇸Northwestern University Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago - Neonatology, Chicago, Illinois, United States
🇬🇧Great Ormond Street, London, United Kingdom
Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19
- Conditions
- Moderate COVID-19-infection
- Interventions
- Drug: human SARS-CoV 2 specific T lymphocytes
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2022-09-15
- Lead Sponsor
- Universitätsklinikum Köln
- Target Recruit Count
- 1
- Registration Number
- NCT04762186
- Locations
- 🇩🇪
Department I for Internal Medicine University Hospital of Cologne, Cologne, NRW, Germany
Effects of Contact Restrictions During the COVID-19 Pandemic on Newborns and Their Parents
- Conditions
- Mother-Child Interaction
- First Posted Date
- 2021-02-01
- Last Posted Date
- 2023-07-14
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 32
- Registration Number
- NCT04732702
- Locations
- 🇩🇪
University hospital of Cologne, Department of Neonatology, Cologne, Northrhine-westfalia, Germany
Characterization of Antibacterial Antibodies in Patients With Cystic Fibrosis
- Conditions
- Neutralizing AntibodiesPulmonary Cystic Fibrosis
- Interventions
- Other: Blood sampling
- First Posted Date
- 2021-01-07
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University Hospital of Cologne
- Target Recruit Count
- 75
- Registration Number
- NCT04700358
- Locations
- 🇩🇪
CF Study Center, University Hospital Cologne, Cologne, Germany
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
- Conditions
- Mitral Regurgitation
- First Posted Date
- 2020-12-29
- Last Posted Date
- 2022-05-17
- Lead Sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Target Recruit Count
- 800
- Registration Number
- NCT04688190
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, Los Angeles, California, United States
🇩🇪Goethe-Universität - University Hospital Frankfurt, Frankfurt, Germany
🇫🇷Civils Hospices of Lyon, Lyon, France
Ketogenic Dietary Interventions in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Conditions
- ADPKD
- Interventions
- Other: Ketogenic dietOther: 3-days water-fastingOther: Control
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2022-08-24
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 63
- Registration Number
- NCT04680780
- Locations
- 🇩🇪
Department II of Internal Medicine, University Hospital of Cologne, Cologne, Germany
Efficacy and Safety of Lomitapide in Paediatric Patients With Homozygous Familial Hypercholesterolaemia (HoFH)
- Conditions
- Homozygous Familial Hypercholesterolaemia (HoFH)
- Interventions
- First Posted Date
- 2020-12-23
- Last Posted Date
- 2024-07-08
- Lead Sponsor
- Amryt Pharma
- Target Recruit Count
- 46
- Registration Number
- NCT04681170
- Locations
- 🇩🇪
University Hospital of Cologne, Cologne, Germany
🇮🇹U.O.C. Clinica Medica 1, Padova, Padua, Italy
🇹🇳E.P.S. Fattouma Bourguiba Hospital, Monastir,, Tunisia
Daratumumab for First Line Treatment of Transplant-ineligible Myeloma Patients Followed by Daratumumab Re-treatment at First Relapse
- First Posted Date
- 2020-12-07
- Last Posted Date
- 2022-04-05
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 160
- Registration Number
- NCT04656951
- Locations
- 🇩🇪
University of Cologne, Cologne, Germany
Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients
- Conditions
- CancerDyspnea, Paroxysmal
- Interventions
- First Posted Date
- 2020-11-19
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 10
- Registration Number
- NCT04635852
- Locations
- 🇩🇪
Study Center Palliative Medicine, Cologne, NRW, Germany
🇩🇪University Hospital Göttingen Center of Palliative Medicine, Göttingen, Hessen, Germany
🇩🇪Hospital Essen- Mitte, Departement of Palliative Medicine, Essen, NRW, Germany
SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Inhalation
- First Posted Date
- 2020-11-17
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- University of Cologne
- Target Recruit Count
- 45
- Registration Number
- NCT04631705
- Locations
- 🇩🇪
University Medical Center Hamburg-Eppendorf, Hamburg, Germany
🇩🇪University Hospital Düsseldorf, Düsseldorf, Germany
🇩🇪University Hospital Frankfurt, Frankfurt am Main, Germany